Autophagy, the major pathway for protein turnover, is critical to maintain cellular homeostasis and has been implicated in neurodegenerative diseases. The aim of this research was to analyze the expression of autophagy markers in postmortem brains from Machado-Joseph disease (MJD) patients. The expression of autophagy markers in the cerebellum and the oculomotor nucleus from MJD patients and age-matched controls with no signs of neuropathology was inspected postmortem by immunohistochemistry (IHC) and Western blot. Furthermore, autophagy was examined by means of transmission electron microscopy (TEM). Western blot and IHC revealed nuclear accumulation of misfolded ataxin-3 (ATXN3) and the presence of ubiquitin-and p62-positive aggregates in MJD patients as compared to controls. Moreover, the autophagic proteins, autophagy-related gene (Atg) protein (ATG)-7, ATG-12, ATG16L2 and autophagosomal microtubule-associated protein light chain 3 (LC3) were significantly increased in MJD brains relative to controls, while beclin-1 levels were reduced in MJD patients. Increase in the levels of lysosomalassociated membrane protein 2 (LAMP-2) and of the endosomal markers (Rab7 and Rab1A) were observed in MJD patients relatively to controls. In addition, these findings were further confirmed by TEM in brain tissue where large vesicles accumulating electron-dense materials were highly enriched in MJD patients. Postmortem brains with MJD exhibit increased markers of autophagy relative to age-matched control brains, therefore suggesting strong dysregulation of autophagy that may have an important role in the course of MJD pathogenesis.
INTRODUCTION
Machado-Joseph disease (MJD) also called spinocerebellar ataxia type 3 (SCA3) is an inherited autosomal dominant progressive neurodegenerative disorder. 1 
MJD belongs to a family of nine additional inherited neurodegenerative polyglutamine (polyQ) disorders, comprising
Huntington's disease (HD), dentatorubral pallidoluysian atrophy (DRPLA), spinobulbar muscular atrophy (SBMA) and SCA types 1, 2, 6, 7 and 17. 2 Despite the fact that MJD is rare, it is the most common ataxia worldwide and reaches high prevalence in particular regions of Portugal, specifically in the archipelago of the Azores. 3 MJD includes neurodegeneration of the cerebellar dentate nucleus, spinocerebellar tracts, Clarke's column, anterior horn cells, substantia nigra and cranial nerve motor nuclei. [4] [5] [6] [7] In addition, in the MJD cerebellum, while the molecular and granular layers are spared, consistent cell loss is observed in the Purkinje cell layer. 8 It results in clinical signs such as limb ataxia, slowness of movements, pyramidal and extrapyramidal signs, gait, dysarthria, dysphagia, dystonia, ophthalmoplegia, myokymia and peripheral neuropathy. [9] [10] [11] [12] [13] [14] MJD/SCA3 is instigated by a meiotically unstable CAG repeat expansion in the coding region of the MJD1 gene encoding an elongated polyQ tract in the C-terminal part of the mutant protein.
It confers a toxic gain of function to the ataxin-3 (ATXN3) protein which abnormally accumulates in MJD neurons. 2, 15 The polyQ tract of MJD patients and at-risk carriers carries approximately 53+ CAG repeats, while it contains between 12 and 40 CAG-repeats in non-affected individuals. 11 The length of the polyQ tract has been correlated with the onset of the disease and severity of MJD symptoms. 16 Correspondence: Sandro Alves, PhD, ICM, Hôpital de la Pitié-Salpêtrière, 47 Bd de l'Hôpital, 75651 Paris Cedex 13, France. Email: sandropfalves@gmail.com ATXN3 is ubiquitously expressed in both neuronal and non-neuronal tissues. [17] [18] [19] [20] ATXN3 is a polyubiquitinbinding protein the physiological function of which has been linked to ubiquitin-mediated proteolysis. Expanded polyQ stretches in the coding region of ATXN3 often result in conformational alterations, therefore prompting the formation of insoluble ubiquitinated inclusions, considered as morphological hallmarks in MJD brains. These intraneuronal inclusions also contain other proteins, like transcription factors and heat shock proteins (HSPs). 18, [20] [21] [22] Despite this, their exact role in SCA3/MJD pathology remains poorly understood. 23 MJD clinical manifestations appear late in life and there is rising evidence that this is linked to a progressive impairment of protein degradation pathways. 24 Two major proteolytic mechanisms contribute to the degradation of polyQ proteins, the ubiquitin-proteasome system and the autophagy-lysosome pathway as reviewed in Ciechanover and Kwon. 25 The main lysosomal degradative pathway in eukaryotic cells, responsible for the degradation of long-lived or aggregated proteins is called macroautophagy, hereafter termed autophagy. 26 Autophagy is an extremely regulated mechanism involving the sequestration of cytoplasmic cargo, like aggregated proteins and injured organelles, which are engulfed within double-membrane vesicles termed autophagosomes, classically labelled by the microtubuleassociated protein 1A/1B-light chain 3 (LC3). 26 In order to accomplish degradation of aggregated proteins by the autophagy-lysosome pathway, there must be an effective fusion of the autophagosomes with the lysosomes. 26 Basal autophagy is critical for the physiology of neurons and autophagy deficit in the central nervous system leads to neurodegeneration. Indeed, the inactivation of key autophagy genes like autophagy-related gene (Atg) proteins 5 (ATG5) and 7 (ATG7) is deleterious in mice. 27, 28 Interestingly, the accumulation of autophagic vesicles has been reported in the striatum of postmortem MJD brains, 29 thus suggesting that autophagy plays a role in the degradation of misfolded ATXN3. Moreover, beclin-1-mediated autophagy was revealed to be beneficial in genetic mouse models of MJD. 29, 30 Few studies have focused on the autophagy/lysosomal degradation in spinocerebellar ataxias. Therefore, to better address the contribution of autophagy in MJD, we analyzed the postmortem cerebellum and the nucleus of cranial nerve no. 3 (oculomotor nucleus), at the level of the mesencephalon -two regions affected in MJD -from MJD patients, as well as postmortem brains from control individuals. In agreement with previous studies in other SCAs, 31 we found an accumulation of markers of the autophagy-lysosome pathway in the brain of MJD patients, thus suggesting that autophagic defects are common hallmarks among SCAs and other neurodegenerative disorders.
MATERIALS AND METHODS

Brain samples from MJD patients and control individuals
In the present investigation, we studied postmortem brains from five patients with clinically, morphologically and genetically diagnosed MJD/SCA3 (carrying between 68 and 81 CAG repeats on the mutant allele; three males, two females, mean age at death 50 AE 6.4 years), along with the brains from five age-matched control individuals (three females, two males, mean age at death 54.4 AE 4.3 years) with no evidence of neurological disease. All brains were obtained from the University Medical Centre Groningen, the Netherlands. Informed consent was obtained from all patients, in accordance with the medical ethics committee of the University Medical Centre Groningen, the Netherlands, where the autopsies were performed. All MJD patients suffered from gait, stance and limb ataxia, dysarthria, dysphagia and a variety of oculomotor dysfunctions. In all cases, these were end-stage disease MJD patients who died due to aspiration pneumonia and/or cachexia, which are the result of dysphagia, a common and severe symptom observed in MJD patients. Genetic diagnosis was carried out in all MJD patients by genotyping the DNA extracted from peripheral lymphocytes with polymorphic dinucleotide repeat sequences that flank the specific ataxin-3 gene loci. 32 In the MJD patients analyzed here, the length of the pathologically expanded polyQ tracts varied from 68 to 81.
Histology
Tissue preparation
The brains of SCA3 patients and age-matched control individuals were fixed in a 4% phosphate-buffered, aqueous formaldehyde solution (pH 7.4). Thereafter, tissue blocks from the left cerebral hemispheres, including the cerebellum and oculomotor nucleus, were embedded in paraffin and cut into 5 μm thick horizontal sections. Alternatively, brain tissue blocks were frozen and conserved at −80 C until processing.
Immunohistochemistry
Five micrometer sections were cut from paraffinembedded brain. 
Image acquisition using optical microscope
Images of immunostained sections were acquired with LAS V3.8 (Leica, Wetzlar, Germany) software, at room temperature, with a bright-field Leica DM 4000B microscope equipped with ×40/0.75 and ×100/1.30 lenses and a Leica DFC500 digital camera. Photographs for comparison were taken under identical conditions of image acquisition and all adjustments of brightness and contrast were applied uniformly to all images.
Western blotting
Whole protein extracts were prepared as described and protein concentrations were determined by standard methods. 33 One hundred micrograms of cerebellar extracts from three MJD patients and three controls were resolved on 5% (mammalian target of rapamycin (mTOR)), 7.5% (ubiquitin), 12% (ATX3, beclin-1, p62, ATG7, ATG12, ATG16L2, lysosomal-associated membrane protein (LAMP)-2) or 15% (LC3, Rab7, Rab1A, acid phosphatase-2 (ACP2)) SDS-polyacrylamide gels. Western blotting procedures were performed as previously described. 33 Blots of whole extracts were stripped and re-probed with antibodies against the corresponding reference protein (alpha-tubulin). The blots were visualized by chemiluminescence (Pierce) on photographic film (Kodak). After development, the images were digitalized and optical densities (OD) were measured using Quantity One 1D image analysis software (version 4.4; Biorad, Hercules, CA, USA). The ODs of the proteins of interest were normalized with respect to a "standard protein" (LC3-I or tubulin) migrating in the same lane. A partition ratio was calculated and normalized with respect to the sample with the highest value defined as 1.
Electron microscopy
The brains of MJD patients and controls were post-fixed in formol/2.5% glutaraldehyde in 0.1 mol/L PBS. Cerebellar sections (50 μm) from MJD patients (n = 2) and healthy controls (n = 2) were cut and post-fixed in 1% osmium tetroxide for 30 min, rinsed in PBS, dehydrated in a graded series of ethanol solutions and embedded in Epon. Ultrathin (70 nm) sections were cut, counterstained with conventional techniques and analyzed with a JEOL 1200EX II electron microscope at 80 kV.
Statistical analysis
ODs of scanned Western blot films were analyzed using the Student's t-test. Significance thresholds were set at P < 0.05 for all tests.
RESULTS
Accumulation of misfolded ATXN3, ubiquitin and p62 aggregates in the cerebellum and oculomotor nucleus of MJD patients
Human postmortem cerebella (cerebellar cortex and dentate nucleus) and oculomotor nucleus, two regions highly affected in MJD, 4 from two cases with MJD and two agematched control individuals with no signs of neurodegeneration were first analyzed by immunohistochemistry to evaluate the presence of misfolded protein by using three different antibodies: the anti-ataxin-3 (ATXN3) (clone 1H9), anti-ubiquitin and anti-p62 antibodies ( Fig. 1A-C) . Patients carrying the MJD1 mutation showed extensive diffuse ATXN3 nuclear immunoreactivity accompanied with ATXN3-positive inclusions in the nucleus of cells from the cerebellar dentate nucleus, relative to controls, where nuclear ATXN3 was hard to detect 1A) . MJD cerebellar Purkinje cells (PCs) showed mostly nuclear diffuse ATXN3, whereas major cytosolic ATXN3 was observed in controls. In the MJD oculomotor nucleus smaller nuclear inclusions, relative to the dentate nucleus, could be observed, but not in control brain cells (Fig. 1A) . Autophagy has been defined as an indispensable cellular pathway for the elimination of ubiquitinated inclusions. 27, 28 Furthermore, the p62/SQSTM1 (sequestosome 1) was recognized as an imperative component of ubiquitin-positive aggregates, permitting its discriminatory degradation through autophagy. 34 Strong accumulation of diffuse p62
protein with small p62-positive aggregates was observed in the dentate nucleus, PCs and oculomotor nucleus of MJD patients, while p62 immunoreactivity remained diffuse in the cell cytoplasm from control brains (Fig. 1B) . This was accompanied by evident nuclear ubiquitin deposition that was not observed in controls (Fig. 1C) . These data were completed with Western blot analysis from cerebellar frozen samples from three MJD brains and three controls that and dentate nucleus) and oculomotor nucleus (counterstained with hematoxylin), from MJD patients (n = 2) and control individuals (n = 2), revealing the presence of diffuse ATXN3 (1H9 immunostaining) accompanied with ATXN3-positive inclusions in the nucleus of cells from the dentate nucleus and oculomotor nucleus, relative to controls, where cytosolic ATXN3 was hard to detect. (B) Nuclear diffuse p62 accompanied with small p62-positive inclusions was detected in the dentate nucleus, Purkinje cells (PCs) and oculomotor nucleus from MJD patients. In control individuals p62 immunoreactivity remained diffuse in the cytosol. (C) Strong diffuse ubiquitin immunoreactivity was observed in the cell nucleus of the above cited regions in MJD patients (n = 2), while no nuclear ubiquitin deposition was observed in controls (n = 2). Representative Western blot of whole cerebellar lysates from MJD patients (n = 3) and healthy controls (n = 3), revealing ATXN3 (1H9 antibody), showing a band with increased molecular weight in MJD patients (D). It was also observed a non-statistically significant increase of the p62 protein in MJD patients relative to controls (D). Ubiquitin levels were increased in MJD patients compared to controls (E). For optical densitometry, quantification signal intensities were normalized to tubulin used as a loading control (F and G). Results are expressed as the mean AE SEM. Statistical analysis was performed using Student's t-test. Bars: 20 μm.
revealed an increase of both p62 (Fig. 1D,F) and ubiquitin (Fig. 1E ,G) levels in MJD patients relative to controls, therefore suggesting that protein clearance pathways may be blocked in MJD patients.
Molecular components specific to the autophagy pathway abnormally accumulate in MJD affected brain regions
The membrane-anchored protein kinase mTOR is a negative regulator of autophagy. Immunohistochemistry showed that mTOR immunoreactivity was increased in the cytosol of MJD cells from the dentate nucleus, cerebellar cortex and oculomotor nucleus, compared to these cell types in control brains ( Fig. 2A) . Furthermore, a strong mTOR nuclear deposition was observed in MJD cells in the above cited regions, but not in control cells ( Fig. 2A) . The beclin-1 protein, which acts independently of mTOR, is implicated in the primary nucleation step of autophagosome formation. Beclin-1-positive inclusions could be detected in the nucleus of cells from dentate nucleus of MJD patients, but not in controls (Fig. 2B) . In control cerebellar PCs, beclin-1 displayed high cytosolic immunoreactivity, while it was completely nuclear and diffuse with small positive inclusions that were hard to detect in PCs from MJD patients (Fig. 2B) . Similar results were visualized in the oculomotor nucleus (Fig. 2B) . Western blot analyses of cerebellar samples demonstrated reduced levels of the soluble beclin-1 protein in MJD patients compared to controls (Fig. 2C,D) , suggesting that the decrease in beclin-1, trapped into aggregates, might impair autophagosome biogenesis, contributing to MJD progression. Next, we analyzed the expression of several autophagic proteins: the autophagy-related gene (ATG)-7, ATG12 and ATG16L2 proteins, which mediate phagophore elongation and completion of the autophagosome. 35 We first investigated whether these proteins accumulated abnormally in the brains of MJD patients; however, no inclusions were detected (Fig. 3A-C) . Interestingly, we found increased immunoreactivity of ATG7, ATG12 and ATG16L2 in the cytoplasm of cells from the MJD dentate nucleus, cerebellar cortex and oculomotor nucleus relative to control cells (Fig. 3A-C) . In accordance, on Western blots of cerebellar lysates, a very strong increase in the levels of ATG7, ATG12 and ATG16L2 was observed in MJD patients compared to brain lysates from control individuals (Fig. 3D,E) . To further determine whether the autophagic response is altered by progressive accumulation of mutant ATXN3, we probed brain sections from MJD patients and healthy controls with two antibodies against the microtubule-associated protein 1A/1B-light chain 3 (LC3). Globally, LC3 and LC3b puncta-like immunoreactivities were found to be strongly increased in the cytoplasm of PCs, dentate nucleus and oculomotor nucleus from MJD patients; only a small accumulation of LC3 was observed in brain sections from controls in these brain regions (Fig. 4A) . On Western blots from cerebellar extracts, LC3-II was increased in MJD patients relative to controls; however, no statistically significant differences were observed (ratio LC3-II/LC3-I, P = 0.07; LC3-II/tubulin, P = 0.08; Student's t-test) (Fig. 4B-D ). These results demonstrate that autophagosomal markers, such as LC3, markedly accumulate in neurons in brain structures that specifically degenerate in MJD.
Late endosomes and lysosomes strongly accumulate in affected brain regions of MJD patients
The LAMPs constitute roughly 50% of the proteins on late endosome and lysosome membranes 36 and are often used as lysosomal markers. In chaperone-mediated autophagy (CMA), the LAMP-2 protein was demonstrated to be a receptor that selectively imports cytosolic proteins to be degraded, into the lysosome. 37 Immunohistochemistry revealed that LAMP-2 immunoreactivity was increased mostly in the cell bodies of cerebellar PCs and in the dentate nucleus of MJD patients relative to controls (Fig. 5A ). Interestingly, no major differences were found in the oculomotor nucleus between MJD patients and controls (Fig. 5A) . Western blot analysis of cerebellar extracts confirmed the increase in LAMP-2 levels in MJD patients compared to controls (Fig. 5E,F) . Next, immunostaining of Cathepsin-D, a major aspartic protease in the lysosomes, had a fine, granular appearance that was more intense in the cytoplasm of cerebellar PCs, dentate nucleus and oculomotor nucleus of MJD patients relative to controls (Fig. 5B ). Rab7 and Rab1A, markers of endosomes, were first analyzed by immunohistochemistry. Rab7 and Rab1A immunohistochemistry revealed a fine and granular staining that was more intense in the cytoplasm of PCs, dentate nucleus and oculomotor nucleus of MJD patients than in controls (Fig. 5C,D) . Western blot demonstrated that both Rab7 and Rab1A levels were~two-fold higher in cerebellar extracts from MJD patients compared to those from control individuals (Fig. 5E,F) . The lysosomal ACP2 protein is an enzyme expressed in the compartment of lysosomes and localized at the lumenal side. Western blot analyses revealed that ACP2 protein levels were increased in cerebellar extracts from MJD patients relative to those from control individuals; however, no statistically significant differences were observed (P = 0.06).
To conclude this study, we investigated the ultrastructural morphology of the dentate nucleus cells in both MJD patients and controls. On electron micrographs, cells from the dentate nucleus of MJD patients, unlike those in controls, showed a larger amount of multi-vesicular bodies and multilamellar bodies almost adjacent to large vacuoles with irregular morphology (Fig. 6C ), which were markedly more frequent relative to control brain cells. The amount and size of amorphous electron-dense structures also increased in the lumen of enlarged lysosomes (Fig. 6D,E) , relative to controls (Fig. 6A,B) . Autophagolysosomes, which are formed by fusion of autophagosomes with lysosomes, often enclosing autophagic vacuoles and increased amounts of amorphous electron-dense content to be degraded (Fig. 6F) , were frequent in MJD brains relative to healthy controls. This configuration might favor the establishment of specialized organelles for the degradation of accumulated misfolded protein in MJD patients. Altogether, these data demonstrate strong accumulation of both endosomes and lysosomal structures in the brains of MJD patients.
DISCUSSION
The implication of the autophagy pathway in several neurodegenerative diseases has been broadly studied over the past few years. The mechanism by which proteins with expanded polyQ tract cause neurodegeneration is not yet fully understood. Formation of aggregates by selfassociation or by interacting with other factors has been proposed. A common mechanism for these neurodegenerative diseases seems to be the incompetent elimination of protein aggregates by autophagy when proteasomal degradation has failed. 26 Despite much research on autophagy-related neuropathogenesis, the mechanisms associated with dysfunction of autophagy during age-related neurodegenerative diseases, including SCA3/MJD, still remain unclear. In this report, we used postmortem brain tissue to demonstrate the anomalous accumulation of markers of the autophagy- proteins, as well as endosomal Rab1A (C) and Rab7 (D) proteins in the cytosol of cells from the MJD cerebellar cortex, dentate nucleus and oculomotor nucleus (n = 2), relative to control cells (n = 2) where the immunoreactivity of these proteins is lower. E) Representative Western blot of whole cerebellar lysates from MJD patients (n = 3) and controls (n = 3), showing increased levels of the LAMP-2, Rab1A and Rab7 protein relative to controls. A non-statistically significant increase (P = 0.06) in the levels of the acid phosphatase-2 (ACP2) protein was observed in MJD patients relative to controls. F) For optical densitometry, quantification signal intensities were normalized to tubulin used as a loading control. Results are expressed as the mean AE SEM. Statistical analysis was performed using Student's t-test. Bars: 20 μm.
lysosomal pathway in the cerebellum and oculomotor nucleus of MJD patients, as demonstrated in the striatum of an MJD mouse model and MJD patients. 29 Autophagy is a mechanism involved in both neurodegeneration and neuroprotection, and has been associated with a wide range of neurodegenerative diseases, including Alzheimer's disease (AD), Parkinson's disease (PD) and Huntington's disease (HD). 38 Aggregation of the disease-causing mutant ATXN3 protein is well established in MJD. 21, 23 At the very least, inclusions are a biomarker of abnormal protein accumulation and impaired protein clearance. In MJD, mutant ATXN3 aggregation can be found in affected regions, such as the dentate nucleus of the cerebellum and oculomotor nucleus, 22 as demonstrated here, but also in other spared brain regions. 39 ATXN3-positive inclusions are strongly ubiquitinated and enclose heat-shock chaperones as well as subunits of the proteasome, suggesting that they are depositories for misfolded aggregated protein. 40 Interestingly, DNAJB family members (heat shock protein 40) were shown to be recruited into nuclear ATXN3 inclusions and depleted from the cytosol. 41 In this report, we show prominent incidence of misfolded ATXN3 protein aggregation in different regions affected in MJD: the dentate nucleus and the oculomotor nucleus, while in the cerebellar cortex, in particular in PCs, ATXN3 is also nuclear but mostly diffuse. Our data are in accordance with previous studies reporting that neither aggregates nor inclusions were present in PC nuclei in any of the MJD/SCA3 cases examined, 42, 43 whereas inclusions were occasionally found in dentate neurons. 42 This apparent absence of intranuclear inclusions in PCs may be apparently paradoxical and difficult to correlate to cell death mechanisms; in addition, it may also suggest a link between intranuclear inclusion deposits and cell death in opposite ways in PCs. Anti-ubiquitin and p62 immunostainings were employed to search for a possible co-localization of ATXN3 inclusions with components of the protein quality control/degradation systems. Given that polyubiquitination is a recognized signal for degradation by the ubiquitinproteasome system (UPS) and that the shuttle protein p62/sequestosome plays a critical role in cellular pathways handling abnormal protein aggregation, 44 such as the autophagy-lysosome system, the positive immunolabeling of aggregates for both ubiquitin and p62 proteins most likely shows an attempt by affected neurons to target misfolded ATXN3 for degradation. Our findings are consistent with several reports describing the presence of insoluble p62 and ubiquitin in ATXN3-positive aggregates in both patients and MJD animal models. 22, 29, 45 Indeed, the p62/SQSTM1 sequestosome binds to poly-ubiquitinated protein aggregates and degrades polyubiquitinated substrates by autophagy via a specific interaction between p62 and the LC3 protein, that labels autophagosomes. 34, 46 Our findings may suggest that the step involving the recognition of the autophagic cargo is functional, given that inclusions are detected by the autophagosomal receptor p62 that participates in the effective targeting of ubiquitinated proteins to autophagosomes, in order to be degraded. 44 In later stages, aggregated p62 in the cell nucleus may be incompetent to remove cargo out of the nucleus into autophagosomal LC3 for autophagy-mediated degradation, as previously suggested. 29 Despite the fact that autophagy is functional in early steps of MJD, mutant ATXN3 gradually accumulates alongside with autophagosomes in MJD late stages, which may indicate that the autophagy pathway possibly becomes overloaded when the amount of mutant ATXN3 synthetized is higher than the degradative ability of the autophagy-lysosome system. 47 Here, we found a strong autophagosomal accumulation in affected regions in MJD brains that could represent increased autophagy in an attempt to clear misfolded ATXN3, or alternatively, defective fusion of autophagosmes within lysosomes, 48 that could limit the capacity to degrade mutant ATXN3 and partially explain the accumulation of ubiquitinated aggregates. Indeed, the increase in LC3-positive punctae does not necessarily reflect high levels of functional autophagy. Furthermore, the pathological accumulation of late endosomal/lysosomal markers, such as Rab1A and Rab7, as well as increased levels of lysosomal markers (LAMP-2) is consistent with delayed or blocked lysosome autophagosome fusion. Therefore it raises the question whether increased Rab7 and Rab1A proteins are elevated in an attempt to clear misfolded ATXN3, as it was suggested for SCA7 pathology. 31 Interestingly, the levels of beclin-1, involved in the initial step of autophagosome formation, were found to be reduced in MJD rodent models, which is in agreement with conditions such as HD 49 and AD, 50 plus the fact that beclin-1 declines in an age-dependent manner in human brains. 49 Here, reduced levels of beclin-1, trapped into aggregates, were observed in neuronal cells from affected MJD regions, suggesting impairments in autophagosome biogenesis that may contribute to autophagy impairment in MJD late stages. Remarkably, a recent study has demonstrated that impaired autophagy in HD could be due, at least in part, to increased beclin-1 degradation. 51 Our data showing reduced levels of beclin-1 in the MJD brain may suggest that dysfunctional autophagy in MJD could be due at least partially to beclin-1 deprivation, as in HD. Despite this, further studies are needed to corroborate this hypothesis. Next, we found increased levels of several ATG-related proteins, ATG7, ATG12 and ATG16L2, crucial for the autophagosome formation, in affected regions from MJD patients, which is in accordance with the findings described in cerebellar samples from SCA7 patients. 31 Despite the fact that our results support the hypothesis that autophagy is impaired in the brain of MJD patients, autophagy is not fully understood. Additional studies are required to ratify whether these alterations result from blocked autophagy. The neuropathological examination of MJD brains provide strong evidence that the disease alters the expression of proteins involved in the autophagy pathway; that is, the redistribution of such proteins, trapped or not within aggregates, as well as autophagosomal accumulation. Altogether this only suggests that the autophagy machinery is compromised, at least in MJD late stages, as observed for SCA7 and AD. 31, 52 In any case, the adjustments in autophagy described here might be a reply in the form of a feed-back survival response by the autophagylysosome system, to the presence of misfolded ATXN3. To conclude, our findings support an impairment of the autophagy-lysosome pathway in MJD patients. Therefore, our report highlights the fact that therapeutic strategies specifically targeting the autophagosomal-lysosomal pathway in MJD may need to be carefully tailored.
